![Karen Knudsen: On behalf of the entire American Cancer Society, I offer our support and well wishes to Dr. Collins](https://oncodaily.com/pub/uploads/2024/04/Screenshot-9.png)
Karen Knudsen: On behalf of the entire American Cancer Society, I offer our support and well wishes to Dr. Collins
Karen Knudsen shared a post by
“Dr. Collins is a brilliant mind who has broken new ground in cancer research. On behalf of the entire American Cancer Society, I offer our support and well wishes as he begins his cancer treatment. We look forward to his full recovery and return to his important work.”
Quoting
“The American Cancer Society stands with Dr. Francis Collins as he navigates his battle with prostate cancer. Dr. Collins‘ groundbreaking work, including his role in the implementation of Cancer Moonshot, has revolutionized cancer research and paved the way for life-changing initiatives. Read more.”
Source: Karen Knudsen/LinkedIn and
Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR). Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.